Assessing Receptor Affinity for Inverse Agonists: Schild and Cheng-Prusoff Methods Revisited

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|8|1|197-202

ISSN： 1389-4501

Source： Current Drug Targets, Vol.8, Iss.1, 2007-01, pp. : 197-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Latest advances in cannabinoid receptor antagonists and inverse agonists

By Muccioli Giulio G   Lambert Didier M  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 10, 2006-10 ,pp. : 1405-1423

Informa Healthcare

Access to resources Recommend Favorite

Novel patent publications on high-affinity nicotinic acid receptor agonists

By Shen Hong C   Colletti Steven L  

Expert Opinion on Therapeutic Patents, Vol. 19, Iss. 7, 2009-07 ,pp. : 957-967

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in histamine H3 receptor antagonists/inverse agonists

By Łażewska Dorota   Kieć-Kononowicz Katarzyna  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 9, 2010-09 ,pp. : 1147-1169

Informa Healthcare

Access to resources Recommend Favorite

Histamine H3-Receptor Inverse Agonists as Novel Antipsychotics

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 9, Iss. 2, 2009-06 ,pp. : 132-136

Bentham Science Publishers

Access to resources Recommend Favorite

Updating the Chemistry and Biology of Cannabinoid CB2 Receptor- Specific Inverse Agonists

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 8, 2010-06 ,pp. : 768-778

Bentham Science Publishers

Access to resources Recommend Favorite